Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for Dyslipidemia and Uric Acid Metabolism
NCT04886297Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- May 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 3 trial of resveratrol in dyslipidemia, sponsored by Sun Yat-sen University. Started May 2021; status: completed.
02
Drugs
resveratrol
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04886297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886297.